课题基金 / 基金详情

Prediction for HCC development and the effect of statin for NASH patients

Prediction for HCC development and the effect of statin for NASH patients
HCC 发展的预测以及他汀类药物对 NASH 患者的作用
批准号:
16K19940
负责人:
HIGASHI Takaaki
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2016
资助国家:
日本
项目状态:
已结题
起止时间:
2016-04-01 至 2018-03-31

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ccell.2016.11.004
发表时间: 2016-12-12
期刊: Cancer cell
影响因子: 50.3
作者: [Nakagawa S, Wei L, Song WM, Higashi T, Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, Goossens N, Bain G, Lauwers GY, Koh AP, El-Abtah M, Ahmad NB, Hoshida H, Erstad DJ, Gunasekaran G, Lee Y, Yu ML, Chuang WL, Dai CY, Kobayashi M, Kumada H, Beppu T, Baba H, Mahajan M, Nair VD, Lanuti M, Villanueva A, Sangiovanni A, Iavarone M, Colombo M, Llovet JM, Subramanian A, Tager AM, Friedman SL, Baumert TF, Schwarz ME, Chung RT, Tanabe KK, Zhang B, Fuchs BC, Hoshida Y, Precision Liver Cancer Prevention Consortium]
通讯作者: Precision Liver Cancer Prevention Consortium
DOI: 10.1016/j.addr.2017.05.007
发表时间: 2017-11-01
期刊: Advanced drug delivery reviews
影响因子: 16.1
作者: [Higashi T, Friedman SL, Hoshida Y]
通讯作者: Hoshida Y
DOI: 10.1016/j.nano.2017.11.004
发表时间: 2018-03
期刊: Nanomedicine : nanotechnology, biology, and medicine
影响因子: --
作者: [Deshmukh M, Nakagawa S, Higashi T, Vincek A, Venkatesh A, Ruiz de Galarreta M, Koh AP, Goossens N, Hirschfield H, Bian CB, Fujiwara N, Ono A, Hoshida H, El-Abtah M, Ahmad NB, Lujambio A, Sanchez R, Fuchs BC, Poelstra K, Prakash J, Hoshida Y, Precision Liver Cancer Prevention Consortium]
通讯作者: Precision Liver Cancer Prevention Consortium
DOI: 10.1038/emm.2017.164
发表时间: 2018-01-05
期刊: Experimental & molecular medicine
影响因子: 12.8
作者: [Hirschfield H, Bian CB, Higashi T, Nakagawa S, Zeleke TZ, Nair VD, Fuchs BC, Hoshida Y]
通讯作者: Hoshida Y